Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-26-126
- Assistance listing (CFDA)
- 93.394
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is soliciting applications for the establishment of the Management and Data Coordination Unit (MDCU), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC). The PCDC will continue to address one of the four research priorities identified in the National Cancer Institute's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma and conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify those patients who are at high risk of progression to cancer. The PCDC-MDCU will provide support toward collaborative efforts such as: study design, protocol development, statistical analysis, coordin...
Related opportunities
- Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)National Institutes of Health
- Network of the National Library of Medicine Training Center (U24 Clinical Trial Not Allowed)National Institutes of HealthUp to $750K
- Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)National Institutes of HealthCloses Nov 2028
- Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed)National Institutes of Health
- Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)National Institutes of Health
- Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)National Institutes of HealthCloses Oct 2026Up to $600K